Citation Impact
Citing Papers
Pazopanib in Locally Advanced or Metastatic Renal Cell Carcinoma: Results of a Randomized Phase III Trial
2010 Standout
Potent Induction of Tumor Immunity by Combining Tumor Cryoablation with Anti–CTLA-4 Therapy
2011 StandoutNobel
Systemic CTLA-4 Blockade Ameliorates Glioma-Induced Changes to the CD4+ T Cell Compartment without Affecting Regulatory T-Cell Function
2007 StandoutNobel
Randomized Phase II/III Trial Assessing Gemcitabine/Carboplatin and Methotrexate/Carboplatin/Vinblastine in Patients With Advanced Urothelial Cancer Who Are Unfit for Cisplatin-Based Chemotherapy: EORTC Study 30986
2011
Distinct Roles for IFN Regulatory Factor (IRF)-3 and IRF-7 in the Activation of Antitumor Properties of Human Macrophages
2006
Cancer statistics, 2022
2022 Standout
Cancer statistics, 2023
2023 Standout
ESUR prostate MR guidelines 2012
2012 Standout
FoxOs Enforce a Progression Checkpoint to Constrain mTORC1-Activated Renal Tumorigenesis
2010 StandoutNobel
Hypoxia-Inducible Factor Linked to Differential Kidney Cancer Risk Seen with Type 2A and Type 2B VHL Mutations
2007 StandoutNobel
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
2024 Standout
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
2021 Standout
Cancer Statistics, 2021
2021 Standout
Modulation of interleukin-18 expression in human colon carcinoma: Consequences for tumor immune surveillance
1999
Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma
2017 Standout
Testicular Germ-Cell Cancer
1997 Standout
Kidney stones: pathophysiology and medical management
2006 Standout
TCR zeta chain lacking exon 7 in two patients with systemic lupus erythematosus
1998
Immunosuppressive networks in the tumour environment and their therapeutic relevance
2005 Standout
mRNA vaccines — a new era in vaccinology
2018 StandoutNobel
Prostate cancer in Asian men
2014
Correlation between Symptom Graduation, Tumor Characteristics and Survival in Renal Cell Carcinoma
2003
Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study
2017 Standout
Racial disparity in renal cell carcinoma patient survival according to demographic and clinical characteristics
2012
Calcium orthophosphates in medicine: from ceramics to calcium phosphate cements
2000
Prophylactic vaccines are potent activators of monocyte-derived dendritic cells and drive effective anti-tumor responses in melanoma patients at the cost of toxicity
2016
MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancer
2014 StandoutNature
EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2013
2013 Standout
Metazoan MicroRNAs
2018 Standout
Altered thymic T-cell selection due to a mutation of the ZAP-70 gene causes autoimmune arthritis in mice
2003 StandoutNatureNobel
The International Society of Urological Pathology (ISUP) Vancouver Classification of Renal Neoplasia
2013
EAU Guidelines on Renal Cell Carcinoma: The 2010 Update
2010
Macrophages and cancer
2008
Critical Analysis of Bladder Sparing with Trimodal Therapy in Muscle-invasive Bladder Cancer: A Systematic Review
2014
Renal-Cell Carcinoma
2005
Bladder cancer
2016 Standout
Potentially clinically relevant prostate cancer is found more frequently after complete than after partial histopathological processing of radical cystoprostatectomy specimens
2012
Histological variants of urothelial carcinoma: diagnostic, therapeutic and prognostic implications
2009
Sorafenib in Advanced Clear-Cell Renal-Cell Carcinoma
2007 Standout
The immune contexture in human tumours: impact on clinical outcome
2012 Standout
Recurrence and Progression of Disease in Non–Muscle-Invasive Bladder Cancer: From Epidemiology to Treatment Strategy
2009 Standout
Tumor microenvironment is multifaceted
2011
Biological and Medical Significance of Calcium Phosphates
2002 Standout
IL-6 and related cytokines as the critical lynchpins between inflammation and cancer
2014
Efficacy of venlafaxine for the prevention and relief of oxaliplatin-induced acute neurotoxicity: results of EFFOX, a randomized, double-blind, placebo-controlled phase III trial
2011
EAU Guidelines on Renal Cell Carcinoma: 2014 Update
2015 Standout
Protective and pathogenic functions of macrophage subsets
2011 Standout
Sex differences in immune responses
2016 Standout
Renal cell carcinoma: Current status and emerging therapies
2007
Renal cell carcinoma: a critical analysis of metabolomic biomarkers emerging from current model systems
2016
Epstein-Barr virus nuclear antigen 2 induces interleukin-18 receptor expression in B cells
2004
Cancer-related inflammation
2008 StandoutNature
Malignant germ cell tumors in men infected with the human immunodeficiency virus: natural history and results of therapy.
1995
Consumption of different types of meat and the risk of renal cancer: meta-analysis of case–control studies
2007
Renal cell carcinoma
2017 Standout
Surgical management of urolithiasis
2002
Exploring the full spectrum of macrophage activation
2008 Standout
NF-κB, inflammation, immunity and cancer: coming of age
2018 Standout
Cytokine expression profile in human pancreatic carcinoma cells and in surgical specimens: implications for survival
2005
Invasive T1 bladder cancer: indications and rationale for radical cystectomy
2008
P2X7 receptor polymorphism and clinical outcomes in HLA-matched sibling allogeneic hematopoietic stem cell transplantation
2007
Metastatic Non-Clear Cell Renal Cell Carcinoma: An Evidence Based Review of Current Treatment Strategies
2015
In vivoblockade of CTLA-4 enhances the priming of responsive T cells but fails to prevent the induction of tumor antigen-specific tolerance
1999 StandoutNobel
Riding the Crest of the Teachable Moment: Promoting Long-Term Health After the Diagnosis of Cancer
2005 Standout
Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome
2006 StandoutScience
Induction of antigen-specific T cell anergy: An early event in the course of tumor progression
1998
MicroRNA-182 drives metastasis of primary sarcomas by targeting multiple genes
2014
Interleukin-10 Increases Th1 Cytokine Production and Cytotoxic Potential in Human Papillomavirus-Specific CD8+Cytotoxic T Lymphocytes
2000
Reply to Anna Orsola, Lluís Cecchini and Juan Morote's Letter to the Editor re: Marko Babjuk, Willem Oosterlinck, Richard Sylvester, et al. EAU Guidelines on Non-Muscle-Invasive Urothelial Carcinoma of the Bladder. Eur Urol 2008;54:303–14
2008
Cancer statistics in China, 2015
2016 Standout
Bladder Cancer
2020 Standout
Elucidating the Autoimmune and Antitumor Effector Mechanisms of a Treatment Based on Cytotoxic T Lymphocyte Antigen-4 Blockade in Combination with a B16 Melanoma Vaccine
2001 StandoutNobel
Immunological and Inflammatory Functions of the Interleukin-1 Family
2009 Standout
Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline
2014 Standout
Prognostic Factors for Overall Survival in Patients With Metastatic Renal Cell Carcinoma Treated With Vascular Endothelial Growth Factor–Targeted Agents: Results From a Large, Multicenter Study
2009 Standout
Insulin and Cancer
2003
Interleukin-10 and the Interleukin-10 Receptor
2001 Standout
Prostate cancer detection with 3 T MRI: Comparison of diffusion‐weighted imaging and dynamic contrast‐enhanced MRI in combination with T2‐weighted imaging
2010
Sex Disparities in Cancer Incidence by Period and Age
2009
CTLA-4-Mediated Inhibition in Regulation of T Cell Responses: Mechanisms and Manipulation in Tumor Immunotherapy
2001 StandoutNobel
The diagnostic accuracy and cost-effectiveness of magnetic resonance spectroscopy and enhanced magnetic resonance imaging techniques in aiding the localisation of prostate abnormalities for biopsy: a systematic review and economic evaluation
2013
Effector Memory T Cells, Early Metastasis, and Survival in Colorectal Cancer
2005 Standout
A Pilot Trial of CTLA-4 Blockade with Human Anti-CTLA-4 in Patients with Hormone-Refractory Prostate Cancer
2007 StandoutNobel
Can Restaging Transurethral Resection of T1 Bladder Cancer Select Patients for Immediate Cystectomy?
2006
Innate NKT lymphocytes confer superior adaptive immunity via tumor-capturing dendritic cells
2005 StandoutNobel
PD-1 blockade therapy in renal cell carcinoma: Current studies and future promises
2015
Comparison of MR/Ultrasound Fusion–Guided Biopsy With Ultrasound-Guided Biopsy for the Diagnosis of Prostate Cancer
2015 Standout
Combination Immunotherapy of B16 Melanoma Using Anti–Cytotoxic T Lymphocyte–Associated Antigen 4 (Ctla-4) and Granulocyte/Macrophage Colony-Stimulating Factor (Gm-Csf)-Producing Vaccines Induces Rejection of Subcutaneous and Metastatic Tumors Accompanied by Autoimmune Depigmentation
1999 StandoutNobel
Elimination of residual metastatic prostate cancer after surgery and adjunctive cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) blockade immunotherapy
1999 StandoutNobel
Works of B Debré being referenced
Chromophobe renal cell carcinoma
2004
Combination of gemcitabine and oxaliplatin in urothelial cancer patients with severe renal or cardiac comorbidities
2005
Risk factors for adult renal cell carcinoma: a systematic review and implications for prevention
2000
Survival Analysis of 130 Patients with Papillary Renal Cell Carcinoma: Prognostic Utility of Type 1 and Type 2 Subclassification
2007
The Value of a Second Transurethral Resection in Evaluating Patients with Bladder Tumours
2003
Negative Prostatic Biopsies in Patients with a High Risk of Prostate Cancer
2005
IL‐18 is produced by prostate cancer cells and secreted in response to interferons
2003
Variable expression of CD3‐ζ chain in tumor‐infiltrating lymphocytes (TIL) derived from renal‐cell carcinoma: Relationship with til phenotype and function
1995
IL-6 is a survival prognostic factor in renal cell carcinoma
1997
microRNA expression profile in a large series of bladder tumors: Identification of a 3‐miRNA signature associated with aggressiveness of muscle‐invasive bladder cancer
2012
Systemic Bacillus Calmette-Guérin Infection, ‘BCGitis’, in PatientsTreated by Intravesical Bacillus Calmette-Guérin Therapy forBladder Cancer
1989
Risk factors for adult renal cell carcinoma
2004
Genitourinary Tumors and HIVi Infection
1990
Concurrent chemoradiotherapy for clinical stage T2 bladder cancer: report of a single institution
2004
Outcome of Patients with Fortuitous Prostate Cancer after Radical Cystoprostatectomy for Bladder Cancer
2005
Clinical Experience with a New Pulsed Dye Laser for Ureteral Stone Lithotripsy
1990
Local immunostimulation induced by intravesical administration of autologous interferon-gamma-activated macrophages in patients with superficial bladder cancer
2002
MANAGEMENT OF PROSTATE CANCER IN CHINA: A MULTICENTER REPORT OF 6 INSTITUTIONS
2005
A comparative study of prostate cancer detection and management in China and in France.
2009
Collecting Duct Carcinoma of the Kidney: A Clinicopathological Study Of 9 Cases
2003
Intravesical Bacillus Calmette-Guerin Therapy for Stage T1 Grade 3 Transitional Cell Carcinoma of the Bladder: Recurrence, Progression and Survival in a Study of 57 Patients
2003
[Urinary calculi, consisting of dehydrated calcium phosphate. Clinical, biological, radiologic aspects, clinical course and management].
1995
645: Survival Analysis of 130 Patients with Papillary Renal Cell Carcinoma. Prognostic Utility of Type 1 and Type 2 Sub Classification
2007
[Sarcomatoid carcinoma with heterologous osteoid differentiation].
2006
[CD4 TIL (Tumor Infiltrating Lymphocytes) induce complete response in patients treated with IL-2 (Interleukin-2). Preliminary study].
1994